Purpose: We studied the efficacy of topically applied lodoxamide tromethamine 0.1% in the treatment of superior limbic keratoconjunctivitis.
Methods: Three patients with clinical findings of bilateral superior limbic keratoconjunctivitis. were treated with topical lodoxamide tromethamine four times daily in both eyes.
Results: While the patients were taking lodoxamide tromethamine, symptoms and objective findings resolved.
Conclusions: Topically applied lodoxamide tromethamine 0.1% is useful in the treatment of superior limbic keratoconjunctivitis. There may be a role for mast cell stabilizers in the treatment of this disorder.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0002-9394(14)72177-4 | DOI Listing |
Publication Analysis
Top Keywords
lodoxamide tromethamine
20
superior limbic
16
treatment superior
12
limbic keratoconjunctivitis
12
topically applied
8
applied lodoxamide
8
tromethamine 01%
8
01% treatment
8
lodoxamide
5
treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!